-       Report 
   - August 2025
    -  184 Pages 
    Global
   
   From       €3181EUR$3,545USD£2,792GBP 
      €3535EUR$3,939USD£3,102GBP 
                -       Report 
   - November 2025
    -  50 Pages 
    Global
   
   From       €2378EUR$2,650USD£2,087GBP 
                      Ferrous Chloride is a hematological drug used to treat iron deficiency anemia. It is a form of iron supplement that is taken orally and is available in both liquid and tablet form. It is used to replenish iron stores in the body and can be used to treat anemia caused by iron deficiency. It is also used to treat anemia caused by other conditions such as chronic kidney disease, pregnancy, and gastrointestinal bleeding. Ferrous Chloride is generally well tolerated and has few side effects.
The Ferrous    Chloride market is a growing segment of the hematological drugs market. It is used to treat a variety of conditions and is widely available. The market is expected to continue to grow as more people are diagnosed with iron deficiency anemia and other conditions that require iron supplementation.
Some companies in the Ferrous Chloride market include Pfizer, Merck, Novartis, and GlaxoSmithKline. Show Less   Read more